Healthcare provider profile · identity verified

Bradley E Kocian, MD

Family Practice · LOUISVILLE, KY · NPI 1841255809

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	394	126
Rosuvastatin Calcium	Rosuvastatin Calcium	292	93
Levothyroxine Sodium	Levothyroxine Sodium	244	78
Amlodipine Besylate	Amlodipine Besylate	243	79
Pantoprazole Sodium	Pantoprazole Sodium	229	74
Losartan Potassium	Losartan Potassium	207	70
Metoprolol Succinate	Metoprolol Succinate	195	66
Gabapentin	Gabapentin	155	35
Lisinopril	Lisinopril	154	52
Metformin Hcl Er	Metformin Hcl	140	45
Hydrochlorothiazide	Hydrochlorothiazide	133	50
Tamsulosin Hcl	Tamsulosin Hcl	117	45
Simvastatin	Simvastatin	113	36
Meloxicam	Meloxicam	112	46
Montelukast Sodium	Montelukast Sodium	105	35
Escitalopram Oxalate	Escitalopram Oxalate	103	36
Omeprazole	Omeprazole	103	38
Ezetimibe	Ezetimibe	75	24
Famotidine	Famotidine	75	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	15
Fluticasone Propionate	Fluticasone Propionate	69	29
Furosemide	Furosemide	69	31
Januvia	Sitagliptin Phosphate	67	19
Allopurinol	Allopurinol	65	19
Metformin Hcl	Metformin Hcl	64	25
Albuterol Sulfate Hfa	Albuterol Sulfate	59	26
Carvedilol	Carvedilol	57	18
Clonazepam	Clonazepam	56	suppressed
Glimepiride	Glimepiride	56	19
Potassium Chloride	Potassium Chloride	56	21
Quetiapine Fumarate	Quetiapine Fumarate	54	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	51	15
Trazodone Hcl	Trazodone Hcl	51	22
Clopidogrel	Clopidogrel Bisulfate	49	17
Diclofenac Sodium	Diclofenac Sodium	49	21
Methylprednisolone	Methylprednisolone	49	44
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	49	suppressed
Duloxetine Hcl	Duloxetine Hcl	44	13
Eliquis	Apixaban	44	12
Synthroid	Levothyroxine Sodium	44	12
Alprazolam	Alprazolam	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	42	11
Bupropion Xl	Bupropion Hcl	42	12
Metoprolol Tartrate	Metoprolol Tartrate	42	13
Citalopram Hbr	Citalopram Hydrobromide	41	14
Ozempic	Semaglutide	41	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	41	12
Atenolol	Atenolol	39	11
Fluoxetine Hcl	Fluoxetine Hcl	39	11
Spironolactone	Spironolactone	37	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	11
Pioglitazone Hcl	Pioglitazone Hcl	35	11
Pravastatin Sodium	Pravastatin Sodium	35	13
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	31
Olmesartan Medoxomil	Olmesartan Medoxomil	31	11
Sertraline Hcl	Sertraline Hcl	31	suppressed
Lorazepam	Lorazepam	30	11
Mirtazapine	Mirtazapine	30	12
Celecoxib	Celecoxib	29	11
Prednisone	Prednisone	28	17
Ibuprofen	Ibuprofen	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	11
Benazepril Hcl	Benazepril Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Jardiance	Empagliflozin	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Morphine Sulfate Er	Morphine Sulfate	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	11
Topiramate	Topiramate	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Azithromycin	Azithromycin	20	19
Finasteride	Finasteride	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Valsartan	Valsartan	19	suppressed
Baclofen	Baclofen	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Lovastatin	Lovastatin	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Repatha Sureclick	Evolocumab	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Estradiol	Estradiol	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Sucralfate	Sucralfate	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	12
Armodafinil	Armodafinil	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Clonidine Hcl	Clonidine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Modafinil	Modafinil	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Ramipril	Ramipril	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error